Home
Conditions
Bronchial Neoplasms

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,263 public trials 1,191 recruiting studies

Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Not Yet Recruiting

Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)

NCT07393555

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Peripheral Blood ETASTs for Predicting Efficacy of Chemoimmunotherapy in NSCLC

NCT07392073

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Advanced Non-Small Cell Lung Cancer, +18 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Sacituzumab Tirumotecan Plus Anlotinib in Previously Treated ES-SCLC

NCT07388875

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small Cell Lung Cancer, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Lung Cancer Screening in Population Who Had Never Smoked

NCT07383454

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +15 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

3-Dimensional Virtual Reality Modelling With Intravascular Indocyanine Green Fluorescence Mapping for Targeted Pulmonary Segmental Resection Trial

NCT06638125

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: St. Joseph's Healthcare Hamilton Hamilton, Ontario, Canada

View Trial Details

Not Yet Recruiting

Clinical Study of SHR-A1811 Combined With Pertuzumab as Second-Line Therapy in Patients With HER2-Altered Advanced NSCLC

NCT07377916

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Predicting Response to Anti-PD-1/PD-L1 Immunotherapy by Plasma Extracellular Vesicle Analysis

NCT07376512

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +19 more
Locations: CHU Besançon - Service Dermatologie Besançon, France

CHU Besançon - Service Pneumologie Oncologie Thoracique Besançon, France

Centre Georges-François Leclerc Dijon, France

CHU Dijon - Service Oncologie Médicale Dijon, France

View Trial Details

Not Yet Recruiting

Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line Induction

NCT07376499

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Association of Different Tidal Volumes and Postoperative Pulmonary Complications

NCT07372378

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +16 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Furmonertinib 160mg vs 80mg + Chemotherapy in EGFR-Mutated NSCLC With Brain Metastases: Efficacy and Safety Study

NCT07365410

Conditions: Brain Diseases, Brain Metastases, Brain Neoplasms, +17 more
Locations: Tianjin Medical University Cancer Institute and Hospital Tianjin, China

View Trial Details

Bronchial Neoplasms

Bronchial Neoplasms trial results

Related conditions